Abstract
Purpose
This study aimed at evaluating the effects of polycystic ovary syndrome (PCOS) and body mass index (BMI) on follicular fluid (FF) adiponectin and ghrelin levels, and on in vitro fertilization outcomes in patients who underwent controlled ovarian hyperstimulation.
Methods
This prospective cross-sectional study was performed with a total of 120 primary infertile women [group 1; non-PCOS = 60 (BMI <25 = 30, BMI ≥25 = 30) and group 2; PCOS = 60 (BMI <25 = 30, BMI ≥25 = 30)]. On the day of oocyte pickup, FF samples were collected.
Results
The FF adiponectin levels were lower in the lean PCOS group than the lean non-PCOS group (p = 0.001), and these levels were lower in the overweight non-PCOS group compared to lean non-PCOS group (0.001). However, there was no difference in the FF ghrelin levels between the groups. Additionally, we could not find a relationship between clinical pregnancy and adiponectin and ghrelin levels.
Conclusion
The FF adiponectin and ghrelin levels have no effects on clinical pregnancy in PCOS. Therefore, further studies are needed to elucidate this issue.
Similar content being viewed by others
References
Ehrmann DA (2005) Polycystic ovary syndrome. N Eng J Med 352:1223–1236
Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC (2006) A meta-analysis of outcomes of conventional IVF in women with polycstic ovary syndrome. Human Reprod Update 12:13–21
Jungheim ES, Schoeller EL, Marquard KL, Louden ED, Schaffer JE, Moley KH (2010) Diet-induced obesity model: abnormal oocytes and persistent growth abnormalities in the offspring. Endocrinology 151:4039–4046
Leroy JLMR, Van Hoeck V, Clemente M, Rizos D, Gutierrez-Adan A, Van Soom A et al (2010) The effect of nutritionally induced hyperlipidaemia on in vitro bovine embryo quality. Hum Reprod 25:768–778
Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB et al (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPAR g agonists: a potential mechanism of insulin sensitization. Endocrinology 143:998–1007
De Vries R, Wolffenbuttel BH, Sluiter WJ, van Tol A, Dullaart RP (2005) Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects. Clin Lab 51(7–8):403–409
Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N et al (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the function of macrophages. Blood 96:1723–1732
Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J (2005) Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 280:18073–18080
Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC (2009) Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 15:297–307
Chabrolle C, Tosca L, Rame C, Lecomte P, Royere D, Dupont J (2009) Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil Steril 92:1988–1996
Takemura Y, Osuga Y, Yamauchi T, Kobayashi M, Harada M, Hirata T et al (2006) Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology 147:3203–3210
Richards JS, Liu Z, Kawai T, Tabata K, Watanabe H, Suresh D et al (2012) Adiponectin and its receptors modulate granulosa cell and cumulus cell functions, fertility, and early embryo development in the mouse and human. Fertil Steril 98:471–479
Bersinger NA, Birkhauser MH, Wunder DM (2006) Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles. Gynecol Endocrinol 22:479–483
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growthhormone- releasing acylated peptide from stomach. Nature 402:656–660
Schofl C, Horn R, Schill T, Schlosser HW, Muller MJ, Brabant G (2002) Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 87:4607–4610
Gaytan F, Barreiro ML, Chopin LK, Herington AC, Morales C, Pinilla L et al (2003) Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab 88:879–887
Barreiro ML, Tena-Sempere M (2004) Ghrelin and reproduction: a novel signal linking energy status and fertility? Mol Cell Endocrinol 29(226):1–9
Viani I, Vottero A, Tassi F, Cremonini G, Sartori C, Bernasconi S et al (2008) Ghrelin inhibits steroid biosynthesis by cultured granulosa-lutein cells. J Clin Endocrinol Metab 93:1476–1481
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
Kale-Gurbuz T, Akhan SE, Bastu E, Telci A, Iyibozkurt AC, Topuz S (2013) Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 26:27–30
Glintborg D, Andersen M, Hagen C, Frystyk J, Hulstrom V, Flyvbjerg A et al (2006) Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 155:337–345
Svendsen PF, Nilas L, Norgaard K, Jensen JE, Madsbad S (2008) Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod 23:2113–2121
Lindholm A, Blomquist C, Bixo M, Dahlbom I, Hansson T, Sundstrom Poromaa I et al (2011) No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weightmatched controls. Hum Reprod 26:1478–1485
Carmina E, Chu MC, Moran C, Tortoriello D, Vardhana P, Tena G et al (2008) Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertil Steril 89:642–648
Bersinger NA, Wunder DM (2010) Adiponectin isoform distribution in serum and in follicular fluid of women undergoing treatment by ICSI. Acta Obstetricia et Gynecologica 89:782–788
Tabandeh MR, Golestani N, Kafi M, Hosseini A, Saeb M, Sarkoohi P (2012) Gene expression pattern of adiponectin and adiponectin receptors in dominant and atretic follicles and oocytes screened based on brilliant cresyl blue staining. Anim Reprod Sci 131:30–40
Takikawa S, Iwase A, Goto M, Harata T, Umezu T, Nakahara T et al (2010) Assessment of the predictive value of follicular fluid insulin, leptin and adiponectin in assisted reproductive cycles. Gynecol Endocrinol 26(7):494–499
Varnagy A, Bodis J, Kovacs GL, Sulyok E, Rauh M, Rascher W (2013) Metabolic hormones in follicular fluid in women undergoing in vitro fertilization. J Reprod Med 58(7–8):305–311
Li L, Ferin M, Sauer MV, Lobo RA (2011) Serum and follicular fluid ghrelin levels negatively reflect human oocyte quality and in vitro embryo development. Fertil Steril 96:1116–1120
Caminos JE, Tena-Sempere M, Gaytan F, Sanchez-Criado JE, Barreiro ML, Nogueiras et al (2003) Expression of ghrelin in the cyclic and pregnant rat ovary. Endocrinology 144(4):1594–1602
Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E (2009) Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin invivo: implications for enhanced insulin sensitivity. Fertil Steril 91(5):1837–1841
Ludwig M, Finas DF, al-Hasani S, Diedrich K, Ortmann O (1999) Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 14:354–358
Mulders AG, Laven JS, Imani B, Eijkemans MJ, Fauser BC (2003) IVF outcome in anovulatory infertility (WHO group 2)—including polycystic ovary syndrome—following previous unsuccessful ovulation induction. Reprod Biomed Online 7:50–58
Esinler I, Bayar U, Bozdag G, Yarali H (2005) Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Fertil Steril 84:932–937
Plachot M, Belaisch-Allart J, Mayenga JM, Chouraqui A, Tesquier A, Serkine AM et al (2003) Oocyte and embryo quality in polycystic ovary syndrome. Gynecol Obstet Fertil. 31:350–354
Sahu B, Ozturk O, Ranierri M, Serhal P (2008) Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet 277(3):239–244
Kdous M, Chaker A, Zhioua A, Zhioua F (2009) Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory. J Gynecol Obstet Biol Reprod (Paris) 38:133–143
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no declarations of interest.
Ethical approval
This study was approved by the local ethics committee and the institutional review board.
Informed consent
Written informed consent was obtained from all volunteers.
Rights and permissions
About this article
Cite this article
Inal, H.A., Yilmaz, N., Gorkem, U. et al. The impact of follicular fluid adiponectin and ghrelin levels based on BMI on IVF outcomes in PCOS. J Endocrinol Invest 39, 431–437 (2016). https://doi.org/10.1007/s40618-015-0392-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0392-6